SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Refocusing SIDS research: Is butylcholinesterase a predictive biomarker?

Matthews, E (2022) Refocusing SIDS research: Is butylcholinesterase a predictive biomarker? EBioMedicine, 81. p. 104104. ISSN 2352-3964 https://doi.org/10.1016/j.ebiom.2022.104104
SGUL Authors: Matthews, Emma Louise

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (99kB) | Preview
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (28kB)
Item Type: Article
Additional Information: © 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: 1103 Clinical Sciences, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: EBioMedicine
ISSN: 2352-3964
Language: eng
Dates:
DateEvent
18 June 2022Published
26 May 2022Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 35728487
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114442
Publisher's version: https://doi.org/10.1016/j.ebiom.2022.104104

Actions (login required)

Edit Item Edit Item